Synoptic reporting improves histopathological assessment of pancreatic resection specimens

Pathology

Volumn 41, Issue 2, 2009, Pages 161-167

  Gill, Anthony J ^a,b   Johns, Amber L ^c   Eckstein, Robert ^a,b   Samra, Jaswinder S ^a,b   Kaufman, Antony ^a   Chang, David K ^c,d   Merrett, Neil D ^d   Cosman, Peter H ^c,d   Smith, Ross C ^a,b   Biankin, Andrew V ^c,d   Kench, James G ^c,e  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d BANKSTOWN LIDCOMBE HOSPITAL   (Australia)

^e WESTMEAD HOSPITAL   (Australia)

Author keywords

Minimum data set; Pancreatic cancer; Synoptic report; Whipple resection

Indexed keywords

ARTICLE; CANCER GRADING; CLINICAL ASSESSMENT; CONTROL GROUP; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH VESSEL; MAJOR CLINICAL STUDY; PANCREAS CANCER; PANCREAS RESECTION; STATISTICAL SIGNIFICANCE; TUMOR VOLUME;

EID: 61649110509     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020802337329     Document Type: Article

References (35)

1. Royal College of Pathologists of Australasia (RCPA). Policy: Synoptic Reports for Major Tumour Types, March 2007. Sydney: RCPA, 2007. http://www.rcpa.edu.au/applications/DocumentLibraryManager/upload/ Synoptic%20Reports%20for%20Major%20Tumour%20Types. pdf (accessed May 2008).
2. The Royal College of Pathologists. Standards and Datasets for Reporting Cancers. London: The Royal College of Pathologists, 2008. http:// www.rcpath.org/index.asp?PageID=254 (accessed May 2008).
3. College of American Pathologists (CAP). Cancer Protocols and Checklists. Northfield, IL: CAP, 2008. http://www.cap.org/apps/cap.portal?- nfpb= true&cntvwrPtlt-actionOverride=%2Fportlets%2FcontentViewer%2 Fshow&-windowLabel=cntvwrPtlt&cntvwrPtlt%7BactionForm.content Reference%7D=cancer-protocols%2Fprotocols-index.html&-state= maximized&-pageLabel=cntvwr (accessed May 2008).
4. Markel SF, Hirsh SD. Perspectives in pathology: synoptic surgical pathology reporting. Hum Pathol 1991; 22: 807-10.
5. Leong AS-Y. Dilemmas in Breast Disease: Synoptic/Checklist Reporting of Breast Biopsies: Has the time come? Breast J 2001; 7: 271-4.
6. Scolyer R, Thompson J, Stretch S, McCarthy S. Collaboration between clinicians and pathologists: a necessity for the optimal management of melanoma patients. Cancer Forum 2005; 29: 76-81.
7. Cross SS, Feeley KM, Angel CA. The effect of four interventions on the informational content of histopathology reports of resected colorectal carcinomas. J Clin Pathol 1998; 51: 481-2.
8. Rigby K, Brown SR, Lakin G, Blasitis M, Hoskie KB. The use of a proforma improves colorectal cancer pathology reporting. Ann R Coll Surg Engl 1999; 81: 401-3.
9. Beattie GC, McAdam TK, Elliott S, Sloan JM, Irwin ST. Improvement in quality of colorectal cancer pathology reporting with a standardized pro-form: a comparative study. Colorectal Dis 2003; 5: 558-62.
10. Zarbo RJ. Interinstitutional assessment of colorectal carcinoma surgical pathology report accuracy: a college of American Pathologists Q-proves study of practice patterns from 532 laboratories and 15 940 reports. Arch Pathol Lab Med 1992; 116: 1113-9.
11. Hammond EH, Flinner RL. Clinically relevant breast cancer reporting: using process measures to improve anatomic pathology reporting. Arch Pathol Lab Med 1997; 121: 1171-5.
12. Harvey JM, Sterret GF, McEvoy S, et al. Pathology reporting of breast cancers: trends in 1989-1999, following the introduction of mammographic screening in Western Australia. Pathology 2005; 37: 341-6.
13. Karim RZ, van den Berg KS, Colman MH, McCarthy SW, Thompson JF, Scolyer RA. The advantage of using a synoptic pathology report format for cutaneous melanoma. Histopathology 2008; 52: 130-8.
14. Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A. Redefining the R1 resection in pancreatic cancer. Br J Surg 2006; 93: 1232-7.
15. Esposito I, Kleef J, Bergmann F, et al. Most pancreatic resections are R1 resections. Ann Surg Oncol 20 March 2008 (e-pub ahead of print).
16. th ed. New York: Springer, 2002.
17. Miettinen O, Nurminen M. Comparative analysis of two rates. Stat Med 1985; 4: 213-26.
18. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat 1979; 6: 65-70.
19. Böttger TC, Störkel S, Wellek S, Störkel M, Junginger T. Factors influencing survival after resection of pancreatic cancer. Cancer 1994; 73: 63-73.
20. Tsuchiya R, Oribe T, Noda T. Size of the tumor and other factors influencing prognosis of carcinoma of the head of the pancreas. Am J Gastroenterol 1985; 80: 459-62.
21. Roder JD, Ott K. Cancer of the pancreas. In: Gospodarowicz MK, Henson DE, Hutter RVP, O'Sullivan B, Sobin LH, Wittekind C, editors. Prognostic Factors in Cancer. New York: Wiley-Liss, 2001; 333.47.
22. Giulianotti PC, Boggi U, Fornaciari G, et al. Prognostic value of histological grading in ductal adenocarcinoma of the pancreas: Klöppel vs TNM grading. Int J Pancreatol 1995; 17: 279-89.
23. Wittekind C, Henson DE, Hutter RVP, Sobin LH, et al., editors. TNM Supplement. A Commentary on Uniform Use. 2nd ed. New York: Wiley-Liss, 2001.
24. Hermanek P. Staging of exocrine pancreatic carcinoma. Eur J Surg Oncol 1991; 17: 167-72.
25. Böttger T, Zech WW, Sorger K, Junginger T. Relevant factors in the prognosis of ductal pancreatic carcinoma. Acta Chir Scand 1990; 156: 781-8.
26. Tsunoda T, Ura K, Eto T, Matsumoto T, Tsuchiya R. UICC and Japanese Stage Classifications for carcinoma of the pancreas. Int J Pancreatol 1991; 8: 205-14.
27. Eskelinen M, Lipponen P. A review of prognostic factors in human pancreatic adenocarcinoma. Cancer Detect Prev 1992; 16: 287-95.
28. Bakkevold KE, Kambesta B. Staging of carcinoma of the pancreas and ampulla of Vater. Int J Pancreatol 1995; 17: 249-59.
29. Compton CC. Pancreatic (Exocrine) Reporting Protocol. Northfield, IL: College of American Pathologists, 2005. http://www.cap.org/apps/docs/cancer- protocols/2005/pancreasexo05-pw.pdf (accessed May 2008).
30. Fortner JG, Klimstra DS, Senie TR, Maclean BJ. Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy. Ann Surg 1996; 223: 147-53.
31. Griffanti-Bartoli F, Arnone GB, Ceppa P, Ravera G, Carrabetta S, Civalleri D. Malignant tumors in the head of the pancreas and the periampullary region, diagnostic and prognostic aspects. Anticancer Res 1994; 14: 657-66.
32. Nagakawa T, Mori K, Nakano T, et al. Perineural invasion of carcinoma of the pancreas and biliary tract. Br J Surg 1993; 80: 619-21.
33. Tannapfel A, Wittekind C, Hunefeld G. Ductal adenocarcinoma of the pancreas. Int J Pancreatol 1992; 12: 145-52.
34. Verbeke CS. Resection margins and R1 rates in pancreatic cancer-are we there yet? Histopathology 2008; 52: 787-96.
35. Kim J, Reber HA, Dry SM, et al. Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins. Gut 2006; 55: 1598-605.